HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takashi Ikeda Selected Research

K 7174

1/2013A low-molecular-weight compound K7174 represses hepcidin: possible therapeutic strategy against anemia of chronic disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takashi Ikeda Research Topics

Disease

17Neoplasms (Cancer)
11/2022 - 06/2006
14Multiple Myeloma
11/2022 - 01/2004
9Hematologic Neoplasms (Hematological Malignancy)
11/2022 - 02/2019
9Lymphoma (Lymphomas)
06/2022 - 03/2010
6Leukemia
06/2020 - 09/2002
5Graft vs Host Disease (Graft-Versus-Host Disease)
01/2022 - 02/2016
5Renal Cell Carcinoma (Grawitz Tumor)
10/2021 - 01/2018
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2022 - 09/2017
4Sarcopenia
01/2022 - 01/2019
4Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
02/2021 - 01/2009
4Thrombocytopenia (Thrombopenia)
02/2021 - 01/2008
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2020 - 03/2010
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2019 - 09/2004
3Osteoarthritis
01/2022 - 06/2018
3Pain (Aches)
08/2021 - 01/2017
3Chronic Kidney Failure (Chronic Renal Failure)
11/2020 - 01/2020
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
09/2020 - 10/2017
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
02/2019 - 11/2005
3Disease Progression
01/2019 - 01/2008
2Residual Neoplasm
11/2022 - 12/2018
2Thrombosis (Thrombus)
04/2022 - 01/2020
2Thyroiditis
02/2021 - 01/2019
2Hypothyroidism
02/2021 - 01/2015
2Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature
12/2020 - 06/2020
2Fever (Fevers)
12/2020 - 11/2009
2Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2020 - 02/2019
2Disseminated Intravascular Coagulation
01/2020 - 02/2019
2Neoplasm Metastasis (Metastasis)
01/2020 - 07/2015
2Brain Neoplasms (Brain Tumor)
10/2019 - 04/2017
2Body Weight (Weight, Body)
10/2019 - 04/2017
2Constipation
11/2017 - 01/2015
2Colorectal Neoplasms (Colorectal Cancer)
11/2017 - 11/2017
2Infections
07/2017 - 01/2008
2Hemorrhage
01/2017 - 01/2009
2Pathologic Constriction (Stenosis)
01/2017 - 03/2010
2Chronic Disease (Chronic Diseases)
01/2013 - 01/2009
2Hepatocellular Carcinoma (Hepatoma)
06/2011 - 11/2009
2Juvenile Myoclonic Epilepsy
09/2006 - 01/2005
1Hemolysis
12/2022
1Tumor Lysis Syndrome
11/2022
1Vomiting
06/2022
1Nausea
06/2022
1Sepsis (Septicemia)
04/2022

Drug/Important Bio-Agent (IBA)

7Dexamethasone (Maxidex)FDA LinkGeneric
11/2022 - 05/2016
7Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2005
5Busulfan (Busulfex)FDA Link
03/2022 - 10/2018
5SteroidsIBA
01/2022 - 01/2008
5Pharmaceutical PreparationsIBA
10/2018 - 01/2008
4Lenalidomide (CC 5013)FDA Link
11/2022 - 05/2016
4Melphalan (Alkeran)FDA LinkGeneric
01/2021 - 05/2016
4Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 01/2009
4Imatinib Mesylate (Gleevec)FDA Link
01/2020 - 09/2004
3Thalidomide (Thalomid)FDA Link
11/2022 - 01/2015
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 02/2018
3Inosine Triphosphate (ITP)IBA
02/2021 - 01/2009
3Rituximab (Mabthera)FDA Link
09/2020 - 01/2011
3Dacarbazine (DIC)FDA LinkGeneric
01/2020 - 02/2019
3Tyrosine Kinase InhibitorsIBA
11/2019 - 01/2018
3Interleukin-2 Receptors (IL 2 Receptor)IBA
09/2019 - 10/2017
2Antineoplastic Agents (Antineoplastics)IBA
06/2022 - 03/2022
2Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
03/2022 - 10/2019
2isatuximabIBA
01/2022 - 12/2020
2NivolumabIBA
10/2021 - 01/2021
2IpilimumabIBA
10/2021 - 01/2021
2Methotrexate (Mexate)FDA LinkGeneric
07/2021 - 01/2016
2Immunoglobulin G (IgG)IBA
02/2021 - 01/2019
2Doxorubicin (Adriamycin)FDA LinkGeneric
09/2020 - 09/2019
2Protease Inhibitors (Protease Inhibitor)IBA
01/2020 - 02/2019
2Branched-Chain Amino AcidsIBA
01/2019 - 06/2018
2Carboplatin (JM8)FDA LinkGeneric
02/2018 - 11/2017
2Biomarkers (Surrogate Marker)IBA
01/2018 - 03/2010
2Anti-Bacterial Agents (Antibiotics)IBA
07/2017 - 01/2016
2Intravenous Immunoglobulins (IVIG)FDA Link
01/2011 - 01/2009
2oleananeIBA
01/2004 - 09/2003
2bardoxoloneIBA
01/2004 - 09/2003
22-cyano-3,12-dioxoolean-1,9-dien-28-oic acidIBA
01/2004 - 09/2003
2TriterpenesIBA
01/2004 - 09/2003
1Complement System Proteins (Complement)IBA
12/2022
1FebuxostatFDA Link
11/2022
1XanthineIBA
11/2022
1Bortezomib (Velcade)FDA Link
11/2022
1daratumumabIBA
11/2022
1Xanthine OxidaseIBA
11/2022
1AntiemeticsIBA
06/2022
1Aprepitant (Emend)FDA Link
06/2022

Therapy/Procedure

26Therapeutics
11/2022 - 01/2004
15Drug Therapy (Chemotherapy)
06/2022 - 03/2010
12Hematopoietic Stem Cell Transplantation
03/2022 - 07/2015
9Transplantation
01/2022 - 11/2005
9Stem Cell Transplantation
01/2022 - 01/2016
6Cell Transplantation
01/2022 - 07/2015
4Hip Replacement Arthroplasty (Total Hip Replacement)
01/2022 - 01/2021
3Catheters
04/2022 - 11/2009
3Activities of Daily Living (ADL)
01/2022 - 01/2021
3Stents
11/2017 - 03/2010
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
12/2020 - 01/2019
2Parenteral Nutrition
10/2019 - 04/2017
2Radiotherapy
09/2019 - 01/2016
2Kidney Transplantation
01/2019 - 07/2016
2Homologous Transplantation
01/2018 - 01/2016